Baseline Immune Biomarkers as Predictors of MBSR(BC) Treatment Success in Off-Treatment Breast Cancer Patients

Biological Research for Nursing

Volumn 16, Issue 4, 2014, Pages 429-437

  Reich, Richard R ^a,b   Lengacher, Cecile A ^b,c   Kip, Kevin E ^c   Shivers, Steven C ^d   Schell, Michael J ^b,e   Shelton, Melissa M ^c   Widen, Raymond H ^f   Newton, Catherine ^e   Barta, Michelle K ^c   Paterson, Carly L ^c   Farias, Jerrica R ^c   Cox, Charles E ^d,e   Klein, Thomas W ^e  

^a UNIVERSITY OF SOUTH FLORIDA SARASOTA MANATEE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f TAMPA GENERAL HOSPITAL   (United States)

Author keywords

biomarkers; breast cancer; mindfulness based stress reduction

Indexed keywords

TUMOR MARKER;

ADULT; AGED; BLOOD; BREAST NEOPLASMS; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHOCYTE SUBSETS; MIDDLE AGED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84907227063     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800413519494     Document Type: Article

References (51)

1. Abud-Mendoza C.,Cuevas-Orta E.,Santillan-Guerrero E. N.,Martinez-Martinez M. U.,Hernandez-Castro B.,Estrada-Capetillo L.Baranda L.Decreased blood levels of B lymphocytes and NK cells in patients with systemic lupus erythematosus (SLE) infected with papillomavirus (HPV).Archives of Dermatological Research. 2012;305:117-123
2. Andersen B. L.,Farrar W. B.,Golden-Kreutz D.,Emery C. F.,Glaser R.,Crespin T.,Carson W. E.Distress reduction from a psychological intervention contributes to improved health for cancer patients.Brain, Behavior and Immunity. 2007;21:953-961
3. Andreyev H. J.,Davidson S. E.,Gillespie C.,Allum W. H.,Swarbrick E.Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.Gut. 2012;61:179-192
4. Bohlmeijer E.,Prenger R.,Taal E.,Cuijpers P.The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: A meta-analysis.Journal of Psychosomatic Research. 2010;68:539-544
5. Bower J. E.,Ganz P. A.,Tao M. L.,Hu W.,Belin T. R.,Sepah S.,Aziz N.Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer.Clinical Cancer Research. 2009;15:5534-5540
6. Carlson L. E.,Speca M.,Faris P.,Patel K. D.One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients.Brain, Behavior, and Immunity. 2007;21:1038-1049
7. Chen M. L.,Lin C. C.Cancer symptom clusters: A validation study.Journal of Pain Symptom Management. 2007;34:590-599
8. Cleeland C. S.,Mendoza T. R.,Wang X. S.,Chou C.,Harle M. T.,Morrissey M.,Engstrom M. C.Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory.Cancer. 2000;89:1634-1646
9. Collado-Hidalgo A.,Bower J. E.,Ganz P. A.,Cole S. W.,Irwin M. R.Inflammatory biomarkers for persistent fatigue in breast cancer survivors.Clinical Cancer Research. 2006;12:2759-2766
10. Cseh A.,Farkas K. M.,Derzbach L.,Muller K.,Vasarhelyi B.,Szalay B.Farkas V.Lymphocyte subsets in pediatric migraine.Neurological Science. 2012;34:1151-1155
11. Dodd M. J.,Cho M. H.,Cooper B. A.,Miaskowski C.The effect of symptom clusters on functional status and quality of life in women with breast cancer.European Journal of Oncology Nursing. 2010;14:101-110
12. Gardner R. V.Long term hematopoietic damage after chemotherapy and cytokine.Frontiers in Bioscience. 1999;4:e47-e57
13. Graham J. E.,Christian L. M.,Kiecolt-Glaser J. K.Stress, age, and immune function: Toward a lifespan approach.Journal of Behavioral Medicine. 2006;29:389-400
14. Grossman P.,Niemann L.,Schmidt S.,Walach H.Mindfulness-based stress reduction and health benefits. A meta-analysis.Journal of Psychosomatic Research. 2004;57:35-43
15. Hofmann S. G.,Sawyer A. T.,Witt A. A.,Oh D.The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review.Journal of Consulting and Clinical Psychology. 2010;78:169-183
16. Hosmer D. W.,Lemeshow S.Applied logistic regression. Hoboken, NJ: John Wiley; 2000:
17. Ivanova M. O.,Ionova T. I.,Kalyadina S. A.,Uspenskaya O. S.,Kishtovich A. V.,Guo H.Wang X. S.Cancer-related symptom assessment in Russia: Validation and utility of the Russian M. D. Anderson Symptom Inventory.Journal of Pain and Symptom Management. 2005;30:443-453
18. Kabat-Zinn J.,Lipworth L.,Burney R.The clinical use of mindfulness meditation for the self-regulation of chronic pain.Journal of Behavioural Medicine. 1985;8:163-190
19. Kang D. H.,Weaver M. T.,Park N. J.,Smith B.,McArdle T.,Carpenter J.Significant impairment in immune recovery after cancer treatment.Nursing Research. 2009;58:105-114
20. Koukourakis G. V.,Zabatis H.,Zacharias G. A.,Koukourakis M. J.Post-surgical irradiation causes cellular immune suppression in patients with breast cancer.European Journal of Cancer Care. 2009;18:306-312
21. Kwon Y. C.,Yun Y. H.,Lee K. H.,Son K. Y.,Park S. M.,Chang Y. J.Cleeland C. S.Symptoms in the lives of terminal cancer patients: Which is the most important?.Oncology. 2006;71:69-76
22. Ledesma D.,Kumano H.Mindfulness-based stress reduction and cancer: A meta-analysis.Psycho-Oncology. 2009;18:571-579
23. Lengacher C. A.,Kip K. E.,Barta M.,Post-White J.,Jacobsen P. B.,Groer M.Shelton M. M.A pilot study evaluating the effect of mindfulness-based stress reduction on psychological status, physical status, salivary cortisol, and interleukin-6 among advanced-stage cancer patients and their caregivers.Journal of Holistic Nursing. 2012;30:170-185
24. Lengacher C. A.,Kip K. E.,Post-White J.,Fitzgerald S.,Newton C.,Barta M.Klein T. W.Lymphocyte recovery after breast cancer treatment and mindfulness-based stress reduction (MBSR) therapy.Biological Research for Nursing. 2013;15:37-47
25. Lengacher C. A.,Reich R. R.,Post-White J.,Moscoso M.,Shelton M. M.,Barta M.Budhrani P.Mindfulness based stress reduction in post-treatment breast cancer patients: An examination of symptoms and symptom clusters.Journal of Behavioural Medicine. 2012;35:86-94
26. Mills P. J.,Ancoli-Israel S.,Parker B.,Natarajan L.,Hong S.,Jain S.von Känel R.Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer.Brain, Behavior, and Immunity. 2008;22:98-104
27. Mozaffari F.,Lindemalm C.,Choudhury A.,Granstam-Bjorneklett H.,Helander I.,Lekander M.Mellstedt H.NK-cell and T-cell functions in patients with breast cancer: Effects of surgery and adjuvant chemo and radiotherapy.British Journal of Cancer. 2007;97:105-111
28. Mozaffari F.,Lindemalm C.,Choudhury A.,Granstam-Bjorneklett H.,Lekander M.,Nilsson B.Mellstedt H.Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: A longitudinal study.Cancer Immunology, Immunotherapy. 2009;58:111-120
29. Nascimbeni M.,Pol S.,Saunier B.Distinct CD4+ CD8+ double-positive T cells in the blood and liver of patients during chronic hepatitis B and C.PLoS One. 2011;6:e20145
30. Nascimbeni M.,Shin E. C.,Chiriboga L.,Kleiner D. E.,Rehermann B.Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions.Blood. 2004;104:478-486
31. Okuyama T.,Wang X. S.,Akechi T.,Mendoza T. R.,Hosaka T.,Cleeland C. S.,Uchitomi Y.Japanese version of the MD Anderson Symptom Inventory: A validation study.Journal of Pain and Symptom Management. 2003;26:1093-1104
32. Parel Y.,Chizzolini C.CD4+ CD8+ double positive (DP) T cells in health and disease.Autoimmunity Reviews. 2004;3:215-220
33. Park J.,Han K.Single-color multitarget flow cytometry using monoclonal antibodies labeled with different intensities of the same fluorochrome.Annals of Laboratory Medicine. 2012;32:171-176
34. Matching alcoholism treatments to client heterogeneity: Treatment main effects and matching effects on drinking during treatment.Journal of Studies on Alcohol. 1998;5:631-639
35. Schwarz M. J.,Chiang S.,Muller N.,Ackenheil M.T-helper-1 and T-helper-2 responses in psychiatric disorders.Brain, Behavior, and Immunity. 2001;15:340-370
36. Sepah S. C.,Bower J. E.Positive affect and inflammation during radiation treatment for breast and prostate cancer.Brain, Behavior, and Immunity. 2009;23:1068-1072
37. Sephton S. E.,Dhabhar F. S.,Keuroghlian A. S.,Giese-Davis J.,McEwen B. S.,Ionan A. C.,Spiegel D.Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer.Brain, Behavior, and Immunity. 2009;23:1148-1155
38. Simon R.Development and validation of biomarker classifiers for treatment selection.Journal of Statistical Planning and Inference. 2008;138:308-320
39. Solomayer E. F.,Feuerer M.,Bai L.,Umansky V.,Beckhove P.,Meyberg G. C.Diel I. J.Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer.Clinical Cancer Research. 2003;9:174-180
40. Standish L. J.,Torkelson C.,Hamill F. A.,Yim D.,Hill-Force A.,Fitzpatrick A.Martzen M. R.Immune defects in breast cancer patients after radiotherapy.Journal of the Society for Integrative Oncology. 2008;6:110-121
41. Toldi G.,Molvarec A.,Stenczer B.,Müller V.,Eszes N.,Bohács A.Tamási L.Peripheral T(h)1/T(h)2/T(h)17/regulatory T-cell balance in asthmatic pregnancy.International Immunology. 2011;23:669-677
42. Torres-Harding S.,Sorenson M.,Jason L. A.,Maher K.,Fletcher M. A.Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS).Bulletin of the International Association for CFS/ME. 2008;16:19-33
43. Tseng T. H.,Cleeland C. S.,Wang X. S.,Lin C. C.Assessing cancer symptoms in adolescents with cancer using the Taiwanese version of the M. D. Anderson Symptom Inventory.Cancer Nursing. 2008;31:E9-E16
44. van der Most R. G.,Currie A.,Robinson B. W.,Lake R. A.Cranking the immunologic engine with chemotherapy: Using context to drive tumor antigen cross-presentation towards useful antitumor immunity.Cancer Research. 2006;66:601-604
45. Von Ah D.,Habermann B.,Carpenter J. S.,Schneider B. L.Impact of perceived cognitive impairment in breast cancer survivors.European Journal of Oncology Nursing. 2013;17:236-241
46. Wang X. S.,Laudico A. V.,Guo H.,Mendoza T. R.,Matsuda M. L.,Yosuico V. D.,Fragante E. P.,Cleeland C. S.Filipino version of the M. D. Anderson Symptom Inventory: Validation and multisymptom measurement in cancer patients.Journal of Pain and Symptom Management. 2006;31:542-552
47. Wang X. S.,Wang Y.,Guo H.,Mendoza T. R.,Hao X. S.,Cleeland C. S.Chinese version of the M. D. Anderson Symptom Inventory: Validation and application of symptom measurement in cancer patients.Cancer. 2004;101:1890-1901
48. Wang X. S.,Williams L. A.,Krishnan S.,Liao Z.,Liu P.,Mao L.Cleeland C. S.Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.Brain, Behavior, and Immunity. 2012;26:699-705
49. Weiss L.,Roux A.,Garcia S.,Demouchy C.,Haeffner-Cavaillon N.,Kazatchkine M. D.,Gougeon M. L.Journal of Infectious Disease. 1998:1158-1162.
50. Wistuba II,Gelovani J. G.,Jacoby J. J.,Davis S. E.,Herbst R. S.Methodological and practical challenges for personalized cancer therapies.Nature Reviews Clinical Oncology. 2011;8:135-141
51. Yamazaki H.,Yoshioka Y.,Inoue T.,Tanaka E.,Nishikubo M.,Sato T.Inoue T.Changes in natural killer cell activity by external radiotherapy and/or brachytherapy.Oncology Reports. 2002;9:359-363